These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12494220)

  • 21. [Treatment with pravastatin of dyslipidemia associated with diabetic nephropathy].
    Robles NR; Ruiz-Calero R; Coronado M; Escola JM; Sánchez Casado E
    An Med Interna; 1998 Nov; 15(11):572-5. PubMed ID: 9882852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.
    Tani S; Watanabe I; Anazawa T; Kawamata H; Tachibana E; Furukawa K; Sato Y; Nagao K; Kanmatsuse K; Kushiro T;
    Am J Cardiol; 2005 Oct; 96(8):1089-94. PubMed ID: 16214443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
    Yorioka N; Masaki T; Ito T; Kushihata S; Nishida Y; Taniguchi Y; Oda H; Yamakido M
    Int J Artif Organs; 2000 Jan; 23(1):27-32. PubMed ID: 12118834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin and coronary heart disease.
    Meyer FP
    N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
    [No Abstract]   [Full Text] [Related]  

  • 27. Generic pravastatin approved.
    FDA Consum; 2006; 40(4):5. PubMed ID: 17243278
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
    Deedwania PC; Hunninghake DB; Bays HE; Jones PH; Cain VA; Blasetto JW;
    Am J Cardiol; 2005 Feb; 95(3):360-6. PubMed ID: 15670545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry.
    Ballantyne CM; Bourge RC; Domalik LJ; Eisen HJ; Fishbein DP; Kubo SH; Lake KD; Radovancevic B; Taylor DO; Ventura HO; Yancy CW; Young JB
    Am J Cardiol; 1996 Sep; 78(5):532-5. PubMed ID: 8806337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria.
    Bell S; Cooney J; Packard CJ; Caslake M; Deighan CJ
    Atherosclerosis; 2009 Jul; 205(1):296-301. PubMed ID: 19150063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia.
    Fogari R; Marasi G; Vanasia A; Zoppi A; Lusardi P; Preti P
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):61-4. PubMed ID: 9147709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of coronary disease using pravastatin in men with hyperlipidemia].
    Evéquoz D
    Praxis (Bern 1994); 1996 Aug; 85(34):989-90. PubMed ID: 8848665
    [No Abstract]   [Full Text] [Related]  

  • 34. Pravastatin administration to hyperlipidemia in patients with nephrotic syndrome.
    Shibasaki T; Nakano H; Matsuda H; Ohno I; Matsumoto H; Misawa T; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1243-8. PubMed ID: 8139136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
    Vivekananthan K; Mehra MR; Uber PA; DeGruiter H; Lavie CJ; Milani RV
    J Assoc Physicians India; 2002 May; 50(5):682-4. PubMed ID: 12186124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of pravastatin on renal function and lipid metabolism in patients with renal dysfunction with hypertension and hyperlipidemia. Pravastatin and Renal Function Research Group.
    Imai Y; Suzuki H; Saito T; Tsuji I; Abe K; Saruta T
    Clin Exp Hypertens; 1999 Nov; 21(8):1345-55. PubMed ID: 10574417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pravastatin improves insulin resistance in dyslipidemic patients.
    Okada K; Maeda N; Kikuchi K; Tatsukawa M; Sawayama Y; Hayashi J
    J Atheroscler Thromb; 2005; 12(6):322-9. PubMed ID: 16394616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes.
    Tomlinson B; Chan P; Lam CWK
    Expert Rev Endocrinol Metab; 2020 May; 15(3):147-157. PubMed ID: 32292091
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins and coronary heart disease.
    Grimes DS
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691942
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease.
    Whyte JJ; Filly AL; Jollis JG
    Am J Cardiol; 1997 Nov; 80(10):1345-7. PubMed ID: 9388112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.